Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sharon Lynch, MD
With
EMD Serono
In addition this study will compare the patients' personal view of how they are doing, any changes in physical disability, and the frequency and severity of relapses over the three year period.
Age
18–60
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Diagnosis of RRMS for at least one year,
Currently on one of three immunomodulatory drugs (Avonex, Copaxone, or Rebif),
Visual Acuity is 20/50 or better,
patient has four color vision,
Must have at least a high school education
You may not be if
History of head injury, drug/alcohol abuse, and/or psychiatric problems, -current diagnosis of a severe or lifethreatening disease other than MS,
currently taking immunosuppressant medication,
resides greater than 200 miles from the study site
Clareo Health | Cognitive Effects of Immunomodulatory Drugs in MS
